ADIL
ADIAL PHARMACEUTICALS, INC.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
2
Buys
2
Sells
0
Largest Trade
$50K–$100K
Insiders
2
Institutional Funds
15
Inst. Value
$100K–$500K
Activist Filings
6
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Schuyler Kevin | Director | BUY | $1K–$15K | 700 | $2.74 | Oct 3, 2023 |
| Newman James W. Jr. | Director | BUY | $50K–$100K | 25K | $2.69 | Jan 3, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 15 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 149K | $15K–$50K | SH |
| VANGUARD GROUP INC | 147K | $15K–$50K | SH |
| JANE STREET GROUP, LLC | 122K | $15K–$50K | SH |
| Virtu Financial LLC | 64K | $1K–$15K | SH |
| Manchester Capital Management LLC | 48K | $1K–$15K | SH |
| BlackRock, Inc. | 28K | $1K–$15K | SH |
| StoneX Group Inc. | 19K | $1K–$15K | SH |
| PRIVATE MANAGEMENT GROUP INC | 10K | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 1K | <$1K | SH |
| WELLS FARGO & COMPANY/MN | 160 | <$1K | SH |
| HARBOUR INVESTMENTS, INC. | 99 | <$1K | SH |
| Abound Wealth Management | 27 | <$1K | SH |
| UBS Group AG | 18 | <$1K | SH |
| MORGAN STANLEY | 9 | <$1K | SH |
| CITIGROUP INC | 1 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 18, 2026
10.0%
2.8M shares
SC 13G · Jun 23, 2025
2.8%
446K shares
SC 13G/A · Nov 14, 2024
5.0%
336K shares
SC 13G · Feb 14, 2024
10.0%
167K shares
SC 13D/A · Feb 18, 2022
4.6%
1.1M shares
SC 13G/A · Feb 14, 2022
4.4%
904K shares